157 related articles for article (PubMed ID: 35244793)
41. Using Genomics Feature Selection Method in Radiomics Pipeline Improves Prognostication Performance in Locally Advanced Esophageal Squamous Cell Carcinoma-A Pilot Study.
Xie CY; Hu YH; Ho JW; Han LJ; Yang H; Wen J; Lam KO; Wong IY; Law SY; Chiu KW; Fu JH; Vardhanabhuti V
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33946826
[TBL] [Abstract][Full Text] [Related]
42. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil PD; Velu PD; Rajiah P; Gilkeson R; Feldman MD; Choi H; Velcheti V; Madabhushi A
Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 33334576
[TBL] [Abstract][Full Text] [Related]
43. Development of a noninvasive tool to preoperatively evaluate the muscular invasiveness of bladder cancer using a radiomics approach.
Zheng J; Kong J; Wu S; Li Y; Cai J; Yu H; Xie W; Qin H; Wu Z; Huang J; Lin T
Cancer; 2019 Dec; 125(24):4388-4398. PubMed ID: 31469418
[TBL] [Abstract][Full Text] [Related]
44. A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma.
Ji GW; Zhu FP; Zhang YD; Liu XS; Wu FY; Wang K; Xia YX; Zhang YD; Jiang WJ; Li XC; Wang XH
Eur Radiol; 2019 Jul; 29(7):3725-3735. PubMed ID: 30915561
[TBL] [Abstract][Full Text] [Related]
45. Intratumoral and Peritumoral Radiomics of Contrast-Enhanced CT for Prediction of Disease-Free Survival and Chemotherapy Response in Stage II/III Gastric Cancer.
Li J; Zhang C; Wei J; Zheng P; Zhang H; Xie Y; Bai J; Zhu Z; Zhou K; Liang X; Xie Y; Qin T
Front Oncol; 2020; 10():552270. PubMed ID: 33425719
[TBL] [Abstract][Full Text] [Related]
46. CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study.
Gu D; Hu Y; Ding H; Wei J; Chen K; Liu H; Zeng M; Tian J
Eur Radiol; 2019 Dec; 29(12):6880-6890. PubMed ID: 31227882
[TBL] [Abstract][Full Text] [Related]
47. Radiomics nomogram for preoperative prediction of progression-free survival using diffusion-weighted imaging in patients with muscle-invasive bladder cancer.
Zhang S; Song M; Zhao Y; Xu S; Sun Q; Zhai G; Liang D; Wu G; Li ZC
Eur J Radiol; 2020 Oct; 131():109219. PubMed ID: 32905953
[TBL] [Abstract][Full Text] [Related]
48. Development and validation of an MRI-based radiomic signature for the preoperative prediction of treatment response in patients with invasive functional pituitary adenoma.
Fan Y; Liu Z; Hou B; Li L; Liu X; Liu Z; Wang R; Lin Y; Feng F; Tian J; Feng M
Eur J Radiol; 2019 Dec; 121():108647. PubMed ID: 31561943
[TBL] [Abstract][Full Text] [Related]
49. A Metabolism-Related Radiomics Signature for Predicting the Prognosis of Colorectal Cancer.
Cai D; Duan X; Wang W; Huang ZP; Zhu Q; Zhong ME; Lv MY; Li CH; Kou WB; Wu XJ; Gao F
Front Mol Biosci; 2020; 7():613918. PubMed ID: 33490106
[No Abstract] [Full Text] [Related]
50. Intratumoral and peritumoral radiomics analysis for preoperative Lauren classification in gastric cancer.
Wang XX; Ding Y; Wang SW; Dong D; Li HL; Chen J; Hu H; Lu C; Tian J; Shan XH
Cancer Imaging; 2020 Nov; 20(1):83. PubMed ID: 33228815
[TBL] [Abstract][Full Text] [Related]
51. Ultrasound-Based Radiomic Nomogram for Predicting Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Tong Y; Li J; Huang Y; Zhou J; Liu T; Guo Y; Yu J; Zhou S; Wang Y; Chang C
Acad Radiol; 2021 Dec; 28(12):1675-1684. PubMed ID: 32782219
[TBL] [Abstract][Full Text] [Related]
52. Parallel comparison and combining effect of radiomic and emerging genomic data for prognostic stratification of non-small cell lung carcinoma patients.
Kim KH; Kim J; Park H; Kim H; Lee SH; Sohn I; Lee HY; Park WY
Thorac Cancer; 2020 Sep; 11(9):2542-2551. PubMed ID: 32700470
[TBL] [Abstract][Full Text] [Related]
53. Development and Validation of a Radiomics Nomogram Model for Predicting Postoperative Recurrence in Patients With Esophageal Squamous Cell Cancer Who Achieved pCR After Neoadjuvant Chemoradiotherapy Followed by Surgery.
Qiu Q; Duan J; Deng H; Han Z; Gu J; Yue NJ; Yin Y
Front Oncol; 2020; 10():1398. PubMed ID: 32850451
[No Abstract] [Full Text] [Related]
54. Predicting Disease-Free Survival With Multiparametric MRI-Derived Radiomic Signature in Cervical Cancer Patients Underwent CCRT.
Liu B; Sun Z; Xu ZL; Zhao HL; Wen DD; Li YA; Zhang F; Hou BX; Huan Y; Wei LC; Zheng MW
Front Oncol; 2021; 11():812993. PubMed ID: 35145910
[TBL] [Abstract][Full Text] [Related]
55. A Nomogram Model to Predict Early Recurrence of Patients With Intrahepatic Cholangiocarcinoma for Adjuvant Chemotherapy Guidance: A Multi-Institutional Analysis.
Li Q; Zhang J; Chen C; Song T; Qiu Y; Mao X; Wu H; He Y; Cheng Z; Zhai W; Li J; Zhang D; Geng Z; Tang Z
Front Oncol; 2022; 12():896764. PubMed ID: 35814440
[TBL] [Abstract][Full Text] [Related]
56. Radiomic Nomogram for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Therapy in Breast Cancer: Predictive Value of Staging Contrast-enhanced CT.
Huang X; Mai J; Huang Y; He L; Chen X; Wu X; Li Y; Yang X; Dong M; Huang J; Zhang F; Liang C; Liu Z
Clin Breast Cancer; 2021 Aug; 21(4):e388-e401. PubMed ID: 33451965
[TBL] [Abstract][Full Text] [Related]
57. The prognostic value of sarcopenia combined with hepatolithiasis in intrahepatic cholangiocarcinoma patients after surgery: A prospective cohort study.
Deng L; Wang Y; Zhao J; Tong Y; Zhang S; Jin C; Chen K; Bao W; Yu Z; Chen G
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):603-612. PubMed ID: 32933804
[TBL] [Abstract][Full Text] [Related]
58. A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.
Lu X; Li M; Zhang H; Hua S; Meng F; Yang H; Li X; Cao D
Phys Med Biol; 2020 Mar; 65(5):055012. PubMed ID: 31978901
[TBL] [Abstract][Full Text] [Related]
59. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
60. Advanced zoomed diffusion-weighted imaging vs. full-field-of-view diffusion-weighted imaging in prostate cancer detection: a radiomic features study.
Hu L; Zhou DW; Fu CX; Benkert T; Jiang CY; Li RT; Wei LM; Zhao JG
Eur Radiol; 2021 Mar; 31(3):1760-1769. PubMed ID: 32935192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
